U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
198871198871Comparison of 2',3'-Dideoxyinosine (Didanosine, ddI) and Zidovudine in Therapy of Patients With the AIDS Dementia ComplexCompletedNo Results AvailableAIDS Dementia Complex|HIV InfectionsDrug: Zidovudine|Drug: Didanosinehttps://ClinicalTrials.gov/show/NCT00000657
198872198872A Phase I/II, Open Label Study to Evaluate the Antiviral Potential of Combination Zidovudine and 2' 3'-Dideoxyinosine (Didanosine) in Patients With Asymptomatic HIV DiseaseCompletedNo Results AvailableHIV InfectionsDrug: Zidovudine|Drug: Didanosinehttps://ClinicalTrials.gov/show/NCT00000656
198873198873A Randomized, Double-Blind Study of 566C80 Versus Septra (Sulfamethoxazole/Trimethoprim) for the Treatment of Pneumocystis Carinii Pneumonia in AIDS PatientsCompletedNo Results AvailablePneumonia, Pneumocystis Carinii|HIV InfectionsDrug: Atovaquone|Drug: Sulfamethoxazole-Trimethoprimhttps://ClinicalTrials.gov/show/NCT00000655
198874198874The Tolerance of HIV-Infected Patients With Herpes Group Virus Infections to Oral Doses of FIAUCompletedNo Results AvailableHerpes Simplex|HIV Infections|Hepatitis BDrug: Fialuridinehttps://ClinicalTrials.gov/show/NCT00000654
198875198875A Trial of Two Doses of 2',3'-Dideoxycytidine (ddC) in the Treatment of Children With Symptomatic HIV Infection Who Are Intolerant of AZT and/or Who Show Progressive Disease While on AZTCompletedNo Results AvailableHIV InfectionsDrug: Zalcitabinehttps://ClinicalTrials.gov/show/NCT00000653
198876198876A Phase I Study to Evaluate the Safety and Toxicity of the Combination of Zidovudine and 2',3'-Dideoxyinosine (Didanosine) in Children With HIV InfectionCompletedNo Results AvailableHIV InfectionsDrug: Zidovudine|Drug: Didanosinehttps://ClinicalTrials.gov/show/NCT00000652
198877198877A Randomized, Double Blind, Comparative Study of Dideoxycytidine (ddC) Alone or ddC/AZT Combination Versus Zidovudine (ZDV) Alone in Patients With HIV Infection Who Have Received Prior ZDV TherapyCompletedNo Results AvailableHIV InfectionsDrug: Zidovudine|Drug: Zalcitabinehttps://ClinicalTrials.gov/show/NCT00000651
198878198878An Assessment of the In Vivo Biological Effects of Diethyldithiocarbamate (DTC) in HIV-Infected PatientsCompletedNo Results AvailableHIV InfectionsDrug: Ditiocarb sodiumhttps://ClinicalTrials.gov/show/NCT00000650
198879198879An Open-Label, Staggered Rising Dose Cohort Study Assessing the Pharmacokinetics, Safety, and Tolerance of BI-RG-587 in Combination With Zidovudine in Patients With HIV Infection (CD4+ Cell Count - CompletedNo Results AvailableHIV InfectionsDrug: Nevirapine|Drug: Zidovudinehttps://ClinicalTrials.gov/show/NCT00000649
198880198880A Pilot Study Evaluating Penicillin G and Ceftriaxone as Therapies for Presumed Neurosyphilis in HIV Seropositive IndividualsCompletedNo Results AvailableHIV Infections|NeurosyphilisDrug: Penicillin G potassium|Drug: Ceftriaxone sodiumhttps://ClinicalTrials.gov/show/NCT00000648
198881198881An Open Trial Combining Zidovudine, Interferon-alfa, and Recombinant CD4-IgG With Transplantation of Syngeneic Bone Marrow and Peripheral Blood Lymphocytes From Healthy gp160-Immunized Donors in the Treatment of Patients With HIV InfectionCompletedNo Results AvailableHIV InfectionsDrug: CD4-IgG|Drug: Zidovudine|Drug: Interferon alfa-n1|Procedure: Peripheral lymphocyte infusion|Procedure: Bone marrow transplanthttps://ClinicalTrials.gov/show/NCT00000647
198882198882Pentoxifylline (Trental) as a Modulator of Tumor Necrosis Factor and of HIV Replication in Patients With AIDSCompletedNo Results AvailableHIV InfectionsDrug: Pentoxifyllinehttps://ClinicalTrials.gov/show/NCT00000646
198883198883A Phase I Dose Escalation Study of Synthetic Hypericin in HIV-Infected Patients With Less Than 300 CD4 LymphocytesCompletedNo Results AvailableHIV InfectionsDrug: Hypericinhttps://ClinicalTrials.gov/show/NCT00000645
198884198884A Phase II Safety and Efficacy Study of Clarithromycin in the Treatment of Disseminated M. Avium Complex (MAC) Infections in Patients With AIDSCompletedNo Results AvailableMycobacterium Avium-intracellulare Infection|HIV InfectionsDrug: Clarithromycinhttps://ClinicalTrials.gov/show/NCT00000644
198885198885Primary Prophylaxis of Cerebral Toxoplasmosis in HIV-Infected PatientsCompletedNo Results AvailableToxoplasmosis, Cerebral|HIV InfectionsDrug: Pyrimethamine|Drug: Leucovorin calciumhttps://ClinicalTrials.gov/show/NCT00000643
198886198886A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in HIV-1 Seropositive Women During the Last Trimester of Pregnancy and Their NewbornsCompletedNo Results AvailableHIV Infections|PregnancyDrug: CD4-IgGhttps://ClinicalTrials.gov/show/NCT00000642
198887198887A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals.CompletedNo Results AvailableMycobacterium Avium-intracellulare Infection|HIV InfectionsDrug: Ciprofloxacin hydrochloride|Drug: Ethambutol hydrochloride|Drug: Amikacin sulfate|Drug: Azithromycin|Drug: Rifampin|Drug: Clofaziminehttps://ClinicalTrials.gov/show/NCT00000641
198888198888A Phase III Comparative Study of Dapsone / Trimethoprim and Clindamycin / Primaquine Versus Sulfamethoxazole / Trimethoprim in the Treatment of Mild-to-Moderate PCP in Patients With AIDSCompletedNo Results AvailablePneumonia, Pneumocystis Carinii|HIV InfectionsDrug: Primaquine|Drug: Sulfamethoxazole-Trimethoprim|Drug: Dapsone|Drug: Clindamycinhttps://ClinicalTrials.gov/show/NCT00000640
198889198889A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine to Amphotericin B Alone Followed by a Comparison of Fluconazole and Itraconazole in the Treatment of Acute Cryptococcal MeningitisCompletedNo Results AvailableMeningitis, Cryptococcal|HIV InfectionsDrug: Itraconazole|Drug: Flucytosine|Drug: Fluconazole|Drug: Amphotericin Bhttps://ClinicalTrials.gov/show/NCT00000639
198890198890Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous InfectionCompletedNo Results AvailableHIV Infections|TuberculosisDrug: Isoniazid|Drug: Pyrazinamide|Drug: Pyridoxine hydrochloride|Drug: Rifampinhttps://ClinicalTrials.gov/show/NCT00000638
198891198891A Randomized Comparative Trial of Zidovudine (AZT) Versus 2',3'-Dideoxyinosine (ddI) Versus AZT Plus ddI in Symptomatic HIV-Infected ChildrenCompletedNo Results AvailableHIV InfectionsDrug: Zidovudine|Drug: Didanosinehttps://ClinicalTrials.gov/show/NCT00000637
198892198892Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous InfectionCompletedNo Results AvailableHIV Infections|TuberculosisDrug: Isoniazid|Drug: Pyrazinamide|Drug: Pyridoxine hydrochloride|Drug: Rifampinhttps://ClinicalTrials.gov/show/NCT00000636
198893198893Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex Disease in Patients With AIDS: Open Label Pilot Study of Topical TrifluridineCompletedNo Results AvailableHerpes Simplex|HIV InfectionsDrug: Trifluridine|Drug: Bacitracin zinc/Polymyxin B sulfatehttps://ClinicalTrials.gov/show/NCT00000635
198894198894A Pilot Pharmacokinetic Phase I Evaluation of BI-RG-587 in HIV-Infected ChildrenCompletedNo Results AvailableHIV InfectionsDrug: Nevirapinehttps://ClinicalTrials.gov/show/NCT00000634
198895198895A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Immuno-AG Recombinant HIV gp160 in Asymptomatic HIV Seropositive IndividualsCompletedNo Results AvailableHIV InfectionsBiological: gp160 Vaccine (Immuno-AG)|Biological: Hepatitis B Vaccine (Recombinant)https://ClinicalTrials.gov/show/NCT00000633
198896198896A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 100 mcg of Env 2-3 in MF59CompletedNo Results AvailableHIV Infections|HIV SeronegativityBiological: Env 2-3https://ClinicalTrials.gov/show/NCT00000632
198897198897A Phase I Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-HIV Envelope Recombinant Vaccine (HIVAC-1e) in Combination With Soluble Recombinant Envelope Vaccine (VaxSyn)CompletedNo Results AvailableHIV InfectionsBiological: HIVAC-1e|Biological: gp160 Vaccine (MicroGeneSys)https://ClinicalTrials.gov/show/NCT00000631
198898198898Phase I Safety and Immunogenicity Trial of Vaccinia-HIV Envelope Recombinant Vaccine (HIVAC-1e) in Combination With Soluble Recombinant Envelope Vaccine (gp160; VaxSyn)CompletedNo Results AvailableHIV InfectionsBiological: HIVAC-1e|Biological: gp160 Vaccine (MicroGeneSys)https://ClinicalTrials.gov/show/NCT00000630
198899198899The Effects of Valproic Acid on Zidovudine Glucuronidation and Pharmacokinetics in HIV-Infected Patients.CompletedNo Results AvailableHIV InfectionsDrug: Valproic acid|Drug: Zidovudinehttps://ClinicalTrials.gov/show/NCT00000629
198900198900A Pharmacokinetic Study of L-697,661 Alone and in Combination With ZidovudineCompletedNo Results AvailableHIV InfectionsDrug: L-697,661|Drug: Zidovudinehttps://ClinicalTrials.gov/show/NCT00000628

* Görseller ve İçerik tekif hakkına sahip olabilir